Heparin Rx

• Women receiving therapeutic-dose unfractionated heparin should have their platelet count monitored at least every other day until day 14 or until the unfractionated heparin is stopped, whichever occurs first.


• Pregnant women who develop heparin-induced thrombocytopenia or have heparin allergy and require continuing anticoagulant therapy should be managed with the heparinoid, danaparoid sodium or fondaparinux, under specialist advice.

• Post-partum, women can be treated with either heparin or warfarin.

• Postpartum warfarin should be avoided until at least the third day and for longer in women at increased risk of postpartum haemorrhage